Telemedicine in French Memory Clinics During the COVID-19 Pandemic

Alexandre Morin (1) , Thibaut Pressat-Laffouilhere (2) , Marie Sarazin (3) , Julien Lagarde (3) , Carole Roue-Jagot (4) , Pauline Olivieri (5, 6, 7, 3) , Claire Paquet (8, 9) , Emmanuel Cognat (10, 9) , Julien Dumurgier (11, 8) , Florence Pasquier (12, 13, 14) , Thibaut Lebouvier (12) , Matthieu Ceccaldi (15) , Olivier Godefroy (16, 17) , Olivier Martinaud (18, 19) , Julien Grosjean (20) , Aline Zarea (21) , David Maltete (2) , David Wallon (2, 22)

1 Service de Neurologie [CHU Pitié-Salpêtrière]
2 CHU Rouen
3 Centre Hospitalier Sainte Anne [Paris]
4 GHU AP-HP Centre Université de Paris
5 USPC - Université Sorbonne Paris Cité
6 IMIV - U1023 - ERL9218 - Imagerie Moléculaire in Vivo
7 SHFJ - Service Hospitalier Frédéric Joliot
8 Hôpital Lariboisière-Fernand-Widal [APHP]
9 OPTeN (UMR_S_1144 / U1144) - Optimisation thérapeutique en Neuropsychopharmacologie
10 Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]
11 CRESS (U1153 / UMR_A_1125 / UMR_S_1153) - Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité
12 CHU Lille
13 LilNCog - Lille Neurosciences & Cognition - U 1172
14 CMRR - Centre Mémoire de Ressources et de Recherche [Lille-Bailleul]
15 APHM - Assistance Publique - Hôpitaux de Marseille
16 LNFP - Laboratoire de Neurosciences Fonctionnelles et Pathologies - UR UPJV 4559
17 CHU Amiens-Picardie
18 NIMH - Neuropsychologie et imagerie de la mémoire humaine
19 CHU Caen
20 Service d'informatique biomédicale [Rouen]
21 Service de neurologie [Rouen]
22 UNIROUEN - Université de Rouen Normandie

This multicenter study was conducted in French memory clinics during the first COVID-2019 lockdown (March-May 2020). The objective was to evaluate the effect of a telemedicine consultation on treatment modification in dementia care. Among 874 patients who had a telemedicine consultation, 103 (10.7%) had treatment modifications, in particular those living with a relative or diagnosed with Alzheimer's disease. A control group of patients referred March-May 2019 was also included. Treatment modification rate was similar between periods with an adjusted percentage difference of -4% (p = 0.27). Telemedicine consultations allowed treatment modifications with only a minor short-term negative impact on therapeutic strategies.

Mots clés: Alzheimer’s disease; COVID-19; Psychoactive drugs; Telemedicine; Treatments in dementia

Domaines: Sciences du Vivant [q-bio]

Alexandre Morin, Thibaut Pressat-Laffouilhere, Marie Sarazin, Julien Lagarde, Carole Roue-Jagot, et al.. Telemedicine in French Memory Clinics During the COVID-19 Pandemic. Journal of Alzheimer's Disease, 2022, 86 (2), pp.525-530. ⟨10.3233/JAD-215459⟩. ⟨hal-03647957⟩